[Other] Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis

batongmd Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-03 00:34
Reward20points

journalㄩExpert Review of Clinical Pharmacology

Authors
Published dateㄩ2024

DOIㄩ      

            10.1080/17512433.2025.2527098

PDF linkㄩhttps://www.tandfonline.com/doi/ ... amp;needAccess=true
Article linkㄩhttps://www.tandfonline.com/doi/ ... amp;needAccess=true
Article Source

Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list